Introduction
============

Cancer has become the second leading cause of death globally, which is characterized as a heterogeneous disease consisting of many different subtypes [@B1]-[@B3]. From the report of the World Health Organization (WHO), there are an estimated 9.6 million deaths due to cancer in 2018 [@B4]. Recently, the development and diagnosis of secondary cancer have become the main concern of cancer survivors [@B5]-[@B7]. In contrast to primary cancer which refers to initial cancer a person experiences, secondary cancer refers to either metastasis from primary cancer, or different cancer unrelated to primary cancer [@B8]. Compared to people with the same age and gender who have never had cancer, cancer survivors have an increased chance of developing secondary cancer. It is important for cancer survivors to be aware of the risk factors for secondary cancers and maintain good follow-up health care [@B9]-[@B11]. Furthermore, the literature shows that secondary cancer should be predicted with regard to their personal risk factors and clinical symptoms [@B12]-[@B15].

Over the years, many statistical methods have been developed to extract knowledge from the clinical data, to identify important risk factors that can be used to prevent the recurrence of diseases [@B16],[@B17]. Tseng et al. [@B18] utilize five classification techniques to rank the importance of risk factors for diagnosing ovarian cancer. Liang et al. [@B19] combine five feature selection methods with support vector machine to develop predictive models for recurrence of hepatocellular carcinoma. However, the studies in [@B18] and [@B19] do not consider the class imbalance problem and the heterogeneity between patients. Similarly, for most existing studies, some do not deal with the class imbalance problem [@B18], some do not consider the heterogeneity between patients [@B20], and as far as we know, none focuses on secondary cancer. The presence of class imbalance is a problem in medical diagnosis, in which the abnormal instances are only a small percentage compared to a large number of normal ones. Especially for secondary cancer, class imbalance is an inevitable problem. For a dataset with class imbalance, machine learning methods are biased towards the majority class and the learned information are mostly from the normal instances, which lead to poor accuracy for identifying the rare abnormal instances. On the other hand, patient heterogeneity is also an important issue to consider. The diagnosis on the basis of data analysis results may not always suitable to a specific patient, given the biological variability among individuals [@B20],[@B21].

In this study, we propose an effective ensemble feature learning method to identify the risk factors for predicting secondary cancer by considering class imbalance and patient heterogeneity. An oversampling method is utilized to deal with the class imbalance problem in secondary cancer. We divide the patients into some heterogeneous groups, and then identify the risk factors and construct a diagnosis model for each patient group for a more accurate prediction. To the best of our knowledge, this kind of methodology has never been proposed and applied for secondary cancer data analysis.

Material and Methods
====================

Samples
-------

The dataset of samples we studied in this paper are provided by the Chung Shan Medical University Hospital, Jen-Ai Hospital, and Far Eastern Memorial Hospital. It mainly contains four types of cancers: breast cancer, maternal cancer, colorectal cancer, head, and neck cancer, where the percentage of secondary cancer patients are 1.7%, 1.8%, 3.6% and 7.9%, respectively. Totally, 11380 patients have ever suffered from primary cancer, among which 458 (4%) patients suffered from secondary cancer. The two classes (no suffering from secondary cancer and suffering from secondary cancer) are highly unbalanced. We analyze the predictor variables to find what variables are associated with the risk factors for secondary cancer. The 20 predictor variables analyzed in this paper are based on the decision of the cancer expert committee, which is considered to be potentially relevant to secondary cancer. They include Age; Body Mass Index (BMI); 8 variables related to the status of cancer which are Primary Site (referred to the type of primary cancer), Histology, Behavior Code, Differentiation, Tumor Size, Pathologic Stage, Surgical Margin, Surgical; 7 variables related to radiological and chemical treatments which are Radiotherapy (RT), Radiotherapy (RT) surgery, Sequence of Local regional Therapy and Systemic Therapy, Dose to clinical target volumes (CTV)\_High, Number to clinical target volumes (CTV)\_High, Dose to clinical target volumes (CTV)\_Low, Number to clinical target volumes (CTV)\_Low; 3 variables related to lifestyle which are: Smoking, Betel Nut, Drinking. The analysis allows for a better understanding of which variables are more fundamental to secondary cancer.

Method design
-------------

Firstly, we divide the training data into some heterogeneous groups by using spectral clustering [@B22],[@B23],[@B24] and learn the training data in each group separately. In each group, we apply the Synthetic minority oversampling technique (SMOTE) [@B25] as the oversampling method to generate synthetic data in the minority class for class balance. Then, ensemble feature learning is performed to identify the risk factors and construct a diagnosis model for each group. In the testing process, each test data is first assigned to a group in the training dataset and then tested the result on the corresponding model.

The procedure of ensemble feature learning mainly consists of four stages, as shown in Figure [1](#F1){ref-type="fig"}.

\(1\) Rank the importance of predictor variables. We use ![](ijmsv16p0949i001.jpg)-test to rank the importance of predictor variables according to their ![](ijmsv16p0949i002.jpg) values. Lower ![](ijmsv16p0949i003.jpg)-value denotes more importance. We set the weight of predictor variables based on the ranking results. For a predictor variable ![](ijmsv16p0949i004.jpg) with rank order ![](ijmsv16p0949i005.jpg), its weight is set as![](ijmsv16p0949i006.jpg), where ![](ijmsv16p0949i007.jpg) is the number of predictor variables.

\(2\) Find out the unimportant predictor variables. We utilize three classifiers, i.e., *k*-nearest neighbor (*k*NN) [@B26], Decision Tree (DT) [@B27] and Support Vector Machine (SVM) [@B28], to classify the samples by increasing the predictor variables based on the ranking result. The predictor variables that do not increase the prediction accuracy are considered to be unimportant. The weights of unimportant predictor variables are set to 0.

\(3\) Calculate the overall importance of predictor variables. For different classifiers, the unimportant predictor variables may be different. We calculate the overall importance of predictor variables as the average weight of using the three classifiers.

\(4\) Select important predictor variables to construct a prediction model. We increase the number of predictor variables from 1 to 20 based on the overall importance in descending order. The combination of predictor variables obtaining the best prediction accuracy is selected for model construction. For example, if the three most important predictor variables obtain the best prediction accuracy, they will be selected for model construction. Beyond the prediction accuracy, we also consider the comments of clinical physicians.

Statistical analysis
--------------------

All statistical analyses are performed using Matlab 9.4.0 (R2018a) on Mac OS X 10.14.2 (18C54) with core i5 CPU and 8GB ram. We apply the AUC (Area Under Curve) [@B29] and ![](ijmsv16p0949i008.jpg) score [@B30] to evaluate the performance of the proposed method. AUC and ![](ijmsv16p0949i009.jpg) score are two useful metrics for imbalanced datasets. AUC is the area under the curve of a ROC graph, which compares the Sensitivity vs (1-Specificity). Each point on the ROC curve represents a different choice for that true/false threshold. ![](ijmsv16p0949i010.jpg) score is a harmonic mean of precision and recall for a specific threshold. AUC evaluates a model independently of the choice of threshold, whereas ![](ijmsv16p0949i011.jpg) score is a measure for a particular model at a particular threshold. In general, AUC evaluates the test power (for best tests nearly 1). ![](ijmsv16p0949i012.jpg) score evaluates how reliable a sensitive test is in the positive decision (nearly 1 for best tests).

We use the toolbox of Matlab to run the three classifiers, i.e., *k*NN, DT and SVM. The spectral clustering algorithm is performed as the algorithm in [@B24]. The training data and test data are 80% and 20%, respectively. We create cross-validation partition for the dataset using Matlab function "cvpartition". For SMOTE, the number of increased samples is ranged from 1 to 15 times of the samples in the minority class, the number of nearest neighbors is ranged from 3 to 13, and the best result is recorded for the following steps. All experiments were repeated 10 times and the average results are reported.

Results
=======

We apply the proposed method to learn the risk factors and predict secondary cancer. The number of divided groups is ranged from 1 to 20. Note that the number of divided groups being 1 is just the case that we apply ensemble feature learning without group division. The results of the prediction accuracies using the three classifiers, i.e., *k*NN, DT and SVM, are shown in Figure [2](#F2){ref-type="fig"}. Figure [2](#F2){ref-type="fig"} shows the results in terms of AUC and ![](ijmsv16p0949i013.jpg) score, respectively. From the results, we can see that ensemble feature learning with group division performs better than ensemble feature learning without group division. DT obtains the best results in the three classifiers. The best results of DT are 0.72 in terms of AUC when dividing into 15 groups, and 0.38 in terms of ![](ijmsv16p0949i014.jpg) score when dividing into 20 groups. The performance of DT shows an upward trend as the number of divided groups increases, while the performance improvements of *k*NN and SVM are not significant when dividing into more than 3 groups.

Next, we show the ranking results based on the importance of the 20 predictor variables in the cases of with and without group division using the DT classifier. For the case of group division, we show the ranking results in each group when dividing into 5 groups. The divided 5 groups are denoted as group 1, group 2, group 3, group 4, and group 5, respectively. As shown in Table [1](#T1){ref-type="table"}, different groups provide different ranking results for the predictor variables. In the case of no group division, the top 5 important predictor variables are Primary Site, Pathologic Stage, Age, Surgical Margin, and Histology. In the case of group division, Primary Site, Pathologic Stage, and Surgical Margin are among the top 5 important predictor variables in each group. Age is among the top 3 important predictor variables in four groups. From the ranking results in Table [1](#T1){ref-type="table"}, Primary Site, Pathologic Stage, Age, Surgical Margin are the four most critical risk factors in groups 2, 3, 5 and the case of no group division.

We further investigate the performance in each group by varying the number of predictor variables. We show the results in Figure [3](#F3){ref-type="fig"} with the same case in Table [1](#T1){ref-type="table"}, i.e., dividing into 5 groups and no group division using DT classifier. In each group, we increase the number of predictor variables from 1 to 20 based on their importance ranking results. Taking the no division case as an example, we first use Primary Site as the predictor variable and then use Primary Site and Pathologic Stage as the two predictor variables. For the no division case, the results do not change obviously as the number of predictor variables varies. For the case of dividing into 5 groups, in each group, the results change obviously as the number of predictor variables varies. Using a certain number of the important predictor variables, the results can be improved significantly. For the best results in terms of AUC, the number of predictor variables used in the no division case is 2, and the numbers of predictor variables used in the group division case are 17, 4, 8,16, 15, respectively.

Finally, to show the effectiveness of the proposed method, we also show the prediction results of the pure *k*NN, pure DT and pure SVM that are without ensemble feature learning. We compare the prediction results of the pure methods to that of the proposed method dividing into different numbers of groups, i.e., 1 group (no division), 5 groups, 10 groups, 15 groups, and 20 groups. The comparison results in terms of AUC and ![](ijmsv16p0949i015.jpg) score are shown in Figures [4](#F4){ref-type="fig"}. From Figure [4](#F4){ref-type="fig"}, we can see that the accuracies of predicting secondary cancer using *k*NN, DT and SVM indeed increase after ensemble feature learning to select the important risk factors as the predictors. Group division to predict secondary cancer on the separated models can further improve the prediction accuracies. Note that the ![](ijmsv16p0949i016.jpg) score of the pure SVM is 0. After ensemble feature learning selecting the important risk factors as the predictors, the ![](ijmsv16p0949i017.jpg) score is improved to be larger than 0.22. DT obtains better results than *k*NN and SVM. The improvements by group division are more significant with the DT method.

Discussion
==========

Whether or not a patient will have secondary cancer depends on many different things [@B18]. In this study, we learn the importance of 20 predictor variables related to secondary cancer for four types of cancer. To the best of our knowledge, this is the first study that utilizes machine learning methods to learn the risk factors and construct the prediction model for secondary cancer.

Based on the data characteristics, i.e., class imbalance and patient heterogeneity, we use an oversampling method to increase the samples in the minority class and use spectral clustering to divide the samples into some groups. Spectral clustering is an efficient clustering algorithm, with the performance being superior to that of traditional clustering methods, such as *K*-means. Compared to no group division in which all patients using only one diagnosis model, group division constructs separated diagnosis models for the patients in different groups. The patients in a group are more similar than the patients in other groups, and they use a diagnosis model. Thus, using the models constructed from the groups has higher precision accuracy than using the model constructed from all samples. That is the reason why group division can improve the accuracy of predicting secondary cancer.

Since for different types of cancers, the ranking results for the predictor variables are different. We also show the ranking results of the importance in the 19 predictor variables (excluding the predictor variable of Primary Site) for each type of cancer. Similar to Table [1](#T1){ref-type="table"}, Tables [2](#T2){ref-type="table"}, 3, 4 and 5 show the ranking results for the four types of cancers, respectively. In no group division case, Age, Pathologic Stage, and Surgical Margin are the three most critical risk factors for maternal cancer, colorectal cancer, head, and neck cancer. For breast cancer, Pathologic Stage, Histology and Surgical Margin are the three most critical risk factors in no group division case. In the group division case, different groups provide different ranking results for the predictor variables. For colorectal cancer, head and neck cancer, Age, Pathologic Stage, and Surgical Margin are the three most critical risk factors in no group division case and remain in the five most critical risk factors in group division case. For breast cancer and maternal cancer, some important predictor variables in no group division case do not remain the same level of importance in group division case, e.g., in Table [3](#T3){ref-type="table"}, age is the most critical risk factor in no group division case, however age is ranked 12 in Group 1 in group division case. One of the reasons is that the patients have similar ages. Another reason is that the number of patients suffering from secondary cancer is only 3. To obtain more samples suffering from secondary cancer to train the diagnosis models, we analyze the four types of cancers together in the experiments.

Limitations and futures studies
-------------------------------

Since there is no existing study using machine learning methods to predict secondary cancer, we have no idea about which kind of machine learning methods are the most suitable. In this study, we try some widely used classification methods for secondary cancer prediction, i.e., *k*-nearest neighbor (*k*NN), Linear Discriminant Analysis (LDA), Quadratic Discriminant Analysis (QDA), Decision Tree (DT) and Support Vector Machine (SVM), and Naïve Bayes. *k*NN, DT and SVM obtain better results than other methods. Thus, we apply *k*NN, DT and SVM in our method for ensemble learning. From the results, we find that DT has better performance than the other two classifiers. That may be because DT uses a tree-like model of decisions, which has similar consideration of group division. Therefore, group division can future improves the performance of DT, especially when the number of divided groups increases. We just try the division of 20 groups, we do not know if increasing the number of divided groups can further improve the performance. In the future, we will try more methods to predict secondary cancer and investigate the optimal number of division groups.

On the other hand, from the dataset, we learn the types of original cancer and which patient has secondary cancer. However, we do not learn about the types of secondary cancer. Learning the types of secondary cancer is useful for therapeutics and preventive [@B31]. This is also one of the future research directions of this study.

Conclusion
==========

The present study shows a proposed method using ensemble feature learning to identify the risk factors for predicting secondary cancer by considering class imbalance and patient heterogeneity. In the proposed method, we divide the training data into some heterogeneous groups and construct a diagnosis model for each group for a more accurate prediction. Analysis of the results shows that the accuracies of predicting secondary cancer indeed increased after using the selected important risk factors as predictors. Group division to predict secondary cancer on the separated models can further improve the prediction accuracies. Our results can provide important references to the personality and clinical symptom representations on all phases of guide interventions, with the complexities of multiple symptoms associated with secondary cancer in all phases of the recurrent trajectory.

This paper is based on results obtained from a project commissioned by the New Energy and Industrial Technology Development Organization (NEDO).
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###### 

Ranking results of the importance in the 20 predictor variables for 4 types of cancers

  Rank   No division                                               5 Groups                                                                                                                                                                                                                                
  ------ --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------------------
  1      Primary Site                                              Pathologic Stage                                          Surgical Margin                                           Primary Site                                              Primary Site                                              Primary Site
  2      Pathologic Stage                                          Primary Site                                              Pathologic Stage\'                                        Pathologic Stage                                          Pathologic Stage                                          Pathologic Stage
  3      Age                                                       Surgical Margin                                           Age                                                       Age                                                       Age                                                       Age
  4      Surgical Margin                                           Surgical                                                  Primary Site                                              Surgical Margin                                           Smoking                                                   Surgical Margin
  5      Histology                                                 Histology                                                 Histology                                                 Smoking                                                   Surgical Margin                                           Smoking
  6      Drinking                                                  Dose to clinical target volumes (CTV)\_Low                Surgical                                                  Number to clinical target volumes (CTV) \_Low             Drinking                                                  Drinking
  7      Betel Nut                                                 Number to clinical target volumes (CTV) \_Low             Number to clinical target volumes (CTV) \_Low             Histology                                                 Betel Nut                                                 Betel Nut
  8      Radiotherapy (RT)                                         Age                                                       Betel Nut                                                 Drinking                                                  Number to clinical target volumes (CTV) \_Low             Histology
  9      Smoking                                                   Tumor Size                                                Tumor Size                                                Betel Nut                                                 Dose to clinical target volumes (CTV)\_High               Number to clinical target volumes (CTV) \_Low
  10     Behavior Code                                             Dose to clinical target volumes (CTV)\_High               Drinking                                                  Dose to clinical target volumes (CTV)\_Low                Histology                                                 Dose to clinical target volumes (CTV)\_High
  11     Sequence of Local regional Therapy and Systemic Therapy   Betel Nut                                                 Smoking                                                   Dose to clinical target volumes (CTV)\_High               Differentiation                                           Differentiation
  12     Body Mass Index (BMI)                                     Drinking                                                  Dose to clinical target volumes (CTV)\_Low                Surgical                                                  Number to clinical target volumes (CTV) \_High            Number to clinical target volumes (CTV) \_High
  13     Number to clinical target volumes (CTV) \_High            Differentiation                                           Dose to clinical target volumes (CTV)\_High               Tumor Size                                                Surgical                                                  Surgical
  14     Differentiation                                           Radiotherapy (RT) surgery                                 Body Mass Index (BMI)                                     Body Mass Index (BMI)                                     Tumor Size                                                Tumor Size
  15     Dose to clinical target volumes (CTV)\_High               Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy   Number to clinical target volumes (CTV) \_High            Body Mass Index (BMI)                                     Body Mass Index (BMI)
  16     Dose to clinical target volumes (CTV)\_Low                Body Mass Index (BMI)                                     Differentiation                                           Differentiation                                           Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy
  17     Number to clinical target volumes (CTV) \_Low             Number to clinical target volumes (CTV) \_High            Radiotherapy (RT) surgery                                 Sequence of Local regional Therapy and Systemic Therapy   Dose to clinical target volumes (CTV)\_Low                Dose to clinical target volumes (CTV)\_Low
  18     Radiotherapy (RT) surgery                                 Smoking                                                   Radiotherapy (RT)                                         Behavior Code                                             Radiotherapy (RT)                                         Radiotherapy (RT)
  19     Tumor Size                                                Behavior Code                                             Number to clinical target volumes (CTV) \_High            Radiotherapy (RT) surgery                                 Behavior Code                                             Behavior Code
  20     Surgical                                                  Radiotherapy (RT)                                         Behavior Code                                             Radiotherapy (RT)                                         Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery

###### 

Ranking results of the importance in the 19 predictor variables for breast cancer

  Rank   No division                                               5 Groups                                                                                                                                                                                                                                
  ------ --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------------------
  1      Pathologic Stage                                          Number to clinical target volumes (CTV) \_High            Surgical Margin                                           Surgical Margin                                           Surgical Margin                                           Surgical Margin
  2      Histology                                                 Dose to clinical target volumes (CTV)\_Low                Pathologic Stage                                          Histology                                                 Smoking                                                   Smoking
  3      Surgical Margin                                           Number to clinical target volumes (CTV) \_Low             Number to clinical target volumes (CTV) \_High            Pathologic Stage                                          Histology                                                 Pathologic Stage
  4      Body Mass Index (BMI)                                     Pathologic Stage                                          Dose to clinical target volumes (CTV)\_Low                Number to clinical target volumes (CTV) \_High            Number to clinical target volumes (CTV) \_High            Histology
  5      Age                                                       Dose to clinical target volumes (CTV)\_High               Body Mass Index (BMI)                                     Dose to clinical target volumes (CTV)\_Low                Dose to clinical target volumes (CTV)\_Low                Number to clinical target volumes (CTV) \_High
  6      Number to clinical target volumes (CTV) \_High            Age                                                       Number to clinical target volumes (CTV) \_Low             Number to clinical target volumes (CTV) \_Low             Pathologic Stage                                          Body Mass Index (BMI)
  7      Betel Nut                                                 Body Mass Index (BMI)                                     Age                                                       Smoking                                                   Number to clinical target volumes (CTV) \_Low             Betel Nut
  8      Dose to clinical target volumes (CTV)\_Low                Surgical Margin                                           Dose to clinical target volumes (CTV)\_High               Body Mass Index (BMI)                                     Body Mass Index (BMI)                                     Drinking
  9      Behavior Code                                             Surgical                                                  Tumor Size                                                Age                                                       Betel Nut                                                 Dose to clinical target volumes (CTV)\_Low
  10     Number to clinical target volumes (CTV) \_Low             Tumor Size                                                Betel Nut                                                 Betel Nut                                                 Surgical                                                  Number to clinical target volumes (CTV) \_Low
  11     Dose to clinical target volumes (CTV)\_High               Histology                                                 Differentiation                                           Dose to clinical target volumes (CTV)\_High               Dose to clinical target volumes (CTV)\_High               Surgical
  12     Tumor Size                                                Betel Nut                                                 Surgical                                                  Surgical                                                  Drinking                                                  Dose to clinical target volumes (CTV)\_High
  13     Differentiation                                           Differentiation                                           Histology                                                 Drinking                                                  Age                                                       Age
  14     Drinking                                                  Radiotherapy (RT)                                         Radiotherapy (RT)                                         Differentiation                                           Radiotherapy (RT)                                         Differentiation
  15     Smoking                                                   Smoking                                                   Drinking                                                  Tumor Size                                                Tumor Size                                                Tumor Size
  16     Radiotherapy (RT)                                         Drinking                                                  Smoking                                                   Radiotherapy (RT)                                         Differentiation                                           Radiotherapy (RT)
  17     Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy   Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery                                 Sequence of Local regional Therapy and Systemic Therapy
  18     Radiotherapy (RT) surgery                                 Behavior Code                                             Behavior Code                                             Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy   Behavior Code
  19     Surgical                                                  Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery                                 Behavior Code                                             Behavior Code                                             Radiotherapy (RT) surgery

###### 

Ranking results of the importance in the 19 predictor variables for maternal cancer

  Rank   No division                                               5 Groups                                                                                                                                                                                                                                
  ------ --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------------------
  1      Age                                                       Surgical Margin                                           Surgical Margin                                           Surgical Margin                                           Surgical Margin                                           Pathologic Stage
  2      Pathologic Stage                                          Smoking                                                   Smoking                                                   Smoking                                                   Pathologic Stage                                          Surgical Margin
  3      Surgical Margin                                           Pathologic Stage                                          Pathologic Stage                                          Pathologic Stage                                          Drinking                                                  Drinking
  4      Body Mass Index (BMI)                                     Histology                                                 Age                                                       Drinking                                                  Sequence of Local regional Therapy and Systemic Therapy   Age
  5      Histology                                                 Body Mass Index (BMI)                                     Histology                                                 Age                                                       Age                                                       Sequence of Local regional Therapy and Systemic Therapy
  6      Betel Nut                                                 Drinking                                                  Body Mass Index (BMI)                                     Histology                                                 Smoking                                                   Smoking
  7      Number to clinical target volumes (CTV) \_High            Betel Nut                                                 Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy   Histology                                                 Histology
  8      Dose to clinical target volumes (CTV)\_Low                Number to clinical target volumes (CTV) \_High            Betel Nut                                                 Body Mass Index (BMI)                                     Number to clinical target volumes (CTV) \_High            Body Mass Index (BMI)
  9      Number to clinical target volumes (CTV) \_Low             Sequence of Local regional Therapy and Systemic Therapy   Dose to clinical target volumes (CTV)\_Low                Number to clinical target volumes (CTV) \_High            Dose to clinical target volumes (CTV)\_Low                Betel Nut
  10     Smoking                                                   Differentiation                                           Drinking                                                  Dose to clinical target volumes (CTV)\_Low                Number to clinical target volumes (CTV) \_Low             Number to clinical target volumes (CTV) \_High
  11     Differentiation                                           Dose to clinical target volumes (CTV)\_Low                Number to clinical target volumes (CTV) \_High            Betel Nut                                                 Body Mass Index (BMI)                                     Dose to clinical target volumes (CTV)\_Low
  12     Radiotherapy (RT) surgery                                 Age                                                       Differentiation                                           Surgical                                                  Differentiation                                           Differentiation
  13     Behavior Code                                             Surgical                                                  Number to clinical target volumes (CTV) \_Low             Number to clinical target volumes (CTV) \_Low             Surgical                                                  Number to clinical target volumes (CTV) \_Low
  14     Radiotherapy (RT)                                         Number to clinical target volumes (CTV) \_Low             Surgical                                                  Radiotherapy (RT)                                         Betel Nut                                                 Surgical
  15     Drinking                                                  Dose to clinical target volumes (CTV)\_High               Radiotherapy (RT)                                         Differentiation                                           Radiotherapy (RT)                                         Radiotherapy (RT)
  16     Tumor Size                                                Tumor Size                                                Dose to clinical target volumes (CTV)\_High               Dose to clinical target volumes (CTV)\_High               Dose to clinical target volumes (CTV)\_High               Dose to clinical target volumes (CTV)\_High
  17     Dose to clinical target volumes (CTV)\_High               Radiotherapy (RT)                                         Tumor Size                                                Tumor Size                                                Tumor Size                                                Tumor Size
  18     Sequence of Local regional Therapy and Systemic Therapy   Behavior Code                                             Behavior Code                                             Behavior Code                                             Behavior Code                                             Behavior Code
  19     Surgical                                                  Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery

###### 

Ranking results of the importance in the 19 predictor variables for colorectal cancer

  Rank   No division                                               5 Groups                                                                                                                                                                                                                                
  ------ --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------------------
  1      Age                                                       Pathologic Stage                                          Pathologic Stage                                          Pathologic Stage                                          Pathologic Stage                                          Pathologic Stage
  2      Pathologic Stage                                          Surgical Margin                                           Surgical Margin                                           Surgical Margin                                           Surgical Margin                                           Age
  3      Surgical Margin                                           Smoking                                                   Smoking                                                   Age                                                       Age                                                       Surgical Margin
  4      Betel Nut                                                 Drinking                                                  Drinking                                                  Smoking                                                   Smoking                                                   Smoking
  5      Histology                                                 Age                                                       Age                                                       Drinking                                                  Drinking                                                  Drinking
  6      Dose to clinical target volumes (CTV)\_Low                Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy
  7      Number to clinical target volumes (CTV) \_High            Body Mass Index (BMI)                                     Body Mass Index (BMI)                                     Betel Nut                                                 Betel Nut                                                 Body Mass Index (BMI)
  8      Body Mass Index (BMI)                                     Betel Nut                                                 Betel Nut                                                 Number to clinical target volumes (CTV) \_Low             Body Mass Index (BMI)                                     Betel Nut
  9      Radiotherapy (RT)                                         Histology                                                 Histology                                                 Body Mass Index (BMI)                                     Number to clinical target volumes (CTV) \_Low             Number to clinical target volumes (CTV) \_Low
  10     Smoking                                                   Number to clinical target volumes (CTV) \_Low             Number to clinical target volumes (CTV) \_Low             Histology                                                 Histology                                                 Dose to clinical target volumes (CTV)\_Low
  11     Drinking                                                  Dose to clinical target volumes (CTV)\_Low                Differentiation                                           Dose to clinical target volumes (CTV)\_Low                Differentiation                                           Histology
  12     Number to clinical target volumes (CTV) \_Low             Number to clinical target volumes (CTV) \_High            Number to clinical target volumes (CTV) \_High            Differentiation                                           Tumor Size                                                Number to clinical target volumes (CTV) \_High
  13     Dose to clinical target volumes (CTV)\_High               Surgical                                                  Dose to clinical target volumes (CTV)\_Low                Number to clinical target volumes (CTV) \_High            Dose to clinical target volumes (CTV)\_Low                Differentiation
  14     Radiotherapy (RT) surgery                                 Differentiation                                           Surgical                                                  Radiotherapy (RT)                                         Radiotherapy (RT)                                         Tumor Size
  15     Differentiation                                           Radiotherapy (RT)                                         Radiotherapy (RT)                                         Tumor Size                                                Number to clinical target volumes (CTV) \_High            Surgical
  16     Behavior Code                                             Dose to clinical target volumes (CTV)\_High               Tumor Size                                                Surgical                                                  Surgical                                                  Radiotherapy (RT)
  17     Tumor Size                                                Tumor Size                                                Dose to clinical target volumes (CTV)\_High               Dose to clinical target volumes (CTV)\_High               Dose to clinical target volumes (CTV)\_High               Dose to clinical target volumes (CTV)\_High
  18     Sequence of Local regional Therapy and Systemic Therapy   Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery                                 Behavior Code                                             Behavior Code                                             Behavior Code
  19     Surgical                                                  Behavior Code                                             Behavior Code                                             Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery

###### 

Ranking results of the importance in the 19 predictor variables for head and neck cancer

  Rank   No division                                               5 Groups                                                                                                                                                                                                                                
  ------ --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------------------
  1      Age                                                       Pathologic Stage                                          Age                                                       Pathologic Stage                                          Age                                                       Pathologic Stage
  2      Pathologic Stage                                          Age                                                       Pathologic Stage                                          Age                                                       Pathologic Stage                                          Age
  3      Surgical Margin                                           Surgical Margin                                           Surgical Margin                                           Surgical Margin                                           Surgical Margin                                           Surgical Margin
  4      Dose to clinical target volumes (CTV)\_Low                Smoking                                                   Smoking                                                   Smoking                                                   Smoking                                                   Drinking
  5      Histology                                                 Drinking                                                  Drinking                                                  Drinking                                                  Body Mass Index (BMI)                                     Smoking
  6      Betel Nut                                                 Body Mass Index (BMI)                                     Body Mass Index (BMI)                                     Body Mass Index (BMI)                                     Drinking                                                  Body Mass Index (BMI)
  7      Body Mass Index (BMI)                                     Betel Nut                                                 Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy   Sequence of Local regional Therapy and Systemic Therapy
  8      Number to clinical target volumes (CTV) \_Low             Sequence of Local regional Therapy and Systemic Therapy   Betel Nut                                                 Betel Nut                                                 Number to clinical target volumes (CTV) \_Low             Betel Nut
  9      Number to clinical target volumes (CTV) \_High            Number to clinical target volumes (CTV) \_Low             Histology                                                 Number to clinical target volumes (CTV) \_Low             Dose to clinical target volumes (CTV) \_Low               Number to clinical target volumes (CTV) \_Low
  10     Drinking                                                  Histology                                                 Number to clinical target volumes (CTV) \_Low             Tumor Size                                                Betel Nut                                                 Dose to clinical target volumes (CTV) \_Low
  11     Differentiation                                           Dose to clinical target volumes (CTV) \_Low               Dose to clinical target volumes (CTV) \_Low               Histology                                                 Histology                                                 Histology
  12     Dose to clinical target volumes (CTV)\_High               Number to clinical target volumes (CTV) \_High            Radiotherapy (RT)                                         Dose to clinical target volumes (CTV) \_Low               Tumor Size                                                Tumor Size
  13     Smoking                                                   Radiotherapy (RT)                                         Differentiation                                           Radiotherapy (RT)                                         Differentiation                                           Differentiation
  14     Radiotherapy (RT)                                         Surgical                                                  Number to clinical target volumes (CTV) \_High            Differentiation                                           Number to clinical target volumes (CTV) \_High            Number to clinical target volumes (CTV) \_High
  15     Radiotherapy (RT) surgery                                 Differentiation                                           Surgical                                                  Number to clinical target volumes (CTV) \_High            Dose to clinical target volumes (CTV) \_High              Dose to clinical target volumes (CTV) \_High
  16     Behavior Code                                             Tumor Size                                                Tumor Size                                                Surgical                                                  Radiotherapy (RT)                                         Radiotherapy (RT)
  17     Sequence of Local regional Therapy and Systemic Therapy   Dose to clinical target volumes (CTV) \_High              Dose to clinical target volumes (CTV) \_High              Dose to clinical target volumes (CTV) \_High              Surgical                                                  Surgical
  18     Tumor Size                                                Behavior Code                                             Behavior Code                                             Behavior Code                                             Behavior Code                                             Behavior Code
  19     Surgical                                                  Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery                                 Radiotherapy (RT) surgery
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